Silicon Investor (SI) -- The First Internet Community

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Biotech / Medical : NEXL -- Ignore unavailable to you. Want to Upgrade?

To: T A P who wrote (1602)	2/10/2000 9:22:00 PM
From: Ace	Read Replies (1) \| Respond to of 1704

Also mentioned on Bloomberg TV 2/9 - Have an active Bio-Technology and Medical Sciences Research product under development. Nexell trading between 1 an 4 offers a opportunity for significant gains over the months ahead Cell/Gene therapy is revolutionizing medicine. Nexell is involved in the treatment of cancer. Nexell is the only company in the US that is approved to do cell selection. Treatment with Nexell products reduces the risk that Chemo will kill the patient. Major life insurance companies are investors.

To: T A P who wrote (1602)	2/10/2000 11:03:00 PM
From: T A P	Read Replies (1) \| Respond to of 1704

NEXL UPDATE!! For the complete updated NEXL write-up go to link below. members.boardhost.com Correction to post #1602 ... The Hotel at which NEXL will present at is the Waldorf Astoria not Westoria. T A P has taken a position in NEXL on the open market and is not compensated in any way by any company mentioned! All information can not be guaranteed but is believed accurate and is for purpose of research and is not a solicitation to buy any security and doing so will be done at your own risk. For more information on NEXL see other posts T A P Internet/Biotech message board. To join T A P free go to T A P profile for url.